Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions

TechCrunch

Neuroglee Therapeutics , a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. million to develop digital therapeutics for neurodegenerative diseases.

[Medisafe in Mobi Health News] Improving digital therapeutics in non-visit based care

OurCrowd

The post [Medisafe in Mobi Health News] Improving digital therapeutics in non-visit based care appeared first on OurCrowd Blog.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Digital Therapeutics. back to fundamentals!

Health Tech Capital

Digital therapeutics. back to fundamentals. will the patients use it? how do you get to the doctors to get a prescription (channel access with pharma reps is not working). and somebody willing to pay for it (payers

Neuroglee gets $2.3 million to develop digital therapeutics for neurodegenerative diseases

TechCrunch

Neuroglee , a Singapore-based health tech startup, wants to help with a digital therapeutic platform created to treat patients in the early stages of the disease. SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmis.

[DarioHealth in PR Newswire] Diabetes and Behavioral Health Global Experts Join DarioHealth Scientific Advisory Board Expanding Innovation Leadership in Digital Therapeutics for Chronic Care D

OurCrowd

The post [DarioHealth in PR Newswire] Diabetes and Behavioral Health Global Experts Join DarioHealth Scientific Advisory Board Expanding Innovation Leadership in Digital Therapeutics for Chronic Care D appeared first on OurCrowd Blog. Marilyn Ritholz, psychologist at Joslin Diabetes Center, a Harvard Medical School affiliate, and Dr. David Horwitz, former Global Chief Medical Officer of Johnson and Johnson Diabetes Institute, will help guide strategic and development roadmap.

[DarioHealth in Yahoo Finance] Dario Health to Host Key Opinion Leader Call on Digital Therapeutics for the Management of Diabetes and Other Chronic Conditions

OurCrowd

Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it will host a key opinion leader (KOL) call on digital therapeutics for the management of diabetes and other chronic conditions on Tuesday, June 23, 2020 at 10:30 a.m.

[DarioHealth in PR Newswire] DarioHealth CEO Erez Raphael Presents to Digital Therapeutics Leaders at DTx East 2019

OurCrowd

NASDAQ: DRIO) (“DarioHealth” or “Dario”), a leading, global digital therapeutics company, today announced that Erez Raphael, DarioHealth’s Chief Executive Officer, will be a speaker at the second annual DTx East 2019 conference taking place at Harvard Medical School in Boston, MA from September 24-26, 2019. DarioHealth Corp.

Ceriter

Leapfunder

Ceriter's Stride One is a medically certified, digital therapeutic that helps patients with Parkinson's walk better and improves recovery for people who suffered a stroke

[Sweetch in DocWire News] Yoni Nevo, CEO, Sweetch, On hyper-personalized engagement platform for chronic conditions

OurCrowd

Sweetch, a digital therapeutics innovator and creator of the hyper-personalized engagement platform for chronic conditions, recently announced the completion of a $20 million Series A round of funding.

metaMe Health Raises $2.2M in Funding

Hyde Park Angels

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M in funding.

health 105

metaMe Health Raises $2.2M in Funding

Hyde Park Angels

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M in funding.

[Sweetch in PR Newswire] Sweetch wins 2022 BIG Innovation Award

OurCrowd

Sweetch, a digital therapeutics innovator and creator of the precision engagement platform for chronic conditions, today announced it has been named a winner in the 2022 BIG Innovation Awards healthcare category, presented by the Business Intelligence Group.

[Sweetch in Israel Hayom] Sweetch named on CB Insights’ list of most innovative digital health startups

OurCrowd

CB Insights on Thursday named Sweetch, a digital therapeutics innovator and creator of a hyper-personalized engagement platform for chronic conditions, to its third annual Digital Health 150, which showcases the 150 most promising private digital health companies in the world.

[Sweetch in PR Newswire] Sweetch Strengthens its Advisory Board with Appointment of Diabetes Care Leader, Dr. Robert A. Gabbay

OurCrowd

TEL AVIV, Israel, April 26, 2022 /PRNewswire/ — Sweetch, a digital therapeutics innovator and creator of the precision engagement platform for chronic conditions, announced today that Robert A.

6 questions investors should ask when evaluating psychedelic biotech companies

TechCrunch

As a venture firm that invests in psychedelics, we receive hundreds of pitches every month from founders developing psychedelic therapeutics. Our fund has invested more than $15 million in companies developing psychedelic therapeutics. Matias Serebrinsky. Contributor. Share on Twitter.

The growing power of digital healthcare: 6 trends to watch in 2022

TechCrunch

4 strategies for building a digital health unicorn. The digital healthcare revolution has already begun, and it will gain further momentum in 2022 as providers and patients look for new and better ways to improve care. Digital therapeutics will rewrite the future of healthcare.

[DarioHealth in Yahoo Finance] Walmart Starts Distributing the DarioHealth Digital Diabetes Management System

OurCrowd

Global digital therapeutics innovation leader, DarioHealth Corp. NASDAQ: DRIO) announced today the launch of the Dario-powered digital diabetes program on Walmart.com. Read more here.

[DarioHealth in PR Newswire] DarioHealth Announces Hiring of Leading Digital Health Innovator as Senior Vice President of Employer Sales

OurCrowd

Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today the appointment of Chris Chan as Senior Vice President of Employer Sales. NEW YORK, Jan. 21, 2021 /PRNewswire/ — DarioHealth Corp.

[Medisafe in Market Insider] Medisafe and Everyday Health Team up to Provide Patients with Coronavirus Updates

OurCrowd

BOSTON, May 13, 2020 /PRNewswire/ — Medisafe, a leading digital therapeutics company providing medication management solutions for patients across the healthcare continuum, today announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services. Read more here.

[DarioHealth in PR Newswire] DarioHealth® Clinical Study Data Shows the Dario Membership Program Assists Diabetes Patients in Achieving Pre-Diabetic Blood-Glucose Levels and Consistent In-Range Measurements

OurCrowd

NASDAQ: DRIO) (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, presented new clinical data yesterday at the American Association of Diabetes Educators (“AADE”) conference in Houston, Texas, which showed remarkable improvements in average blood-glucose levels and in-range measurements in patients with diabetes using Dario’s digital therapeutics platform and dedicated one-on-one personal health coaching.

[DarioHealth in Yahoo Finance] DarioHealth Announces Poster Presentation at the Virtual Association of Diabetes Care and Education Specialists 2020 Annual Conference

OurCrowd

Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual Association of Diabetes Care and Education Specialists (ADCES) 2020 Annual Conference, Read more here.

[Medisafe in PR Newswire] Medisafe Adds Pharmacy Integration to Its Platform, Now Delivers Medications to Patients

OurCrowd

[Medisafe in New Kerala] Medisafe and Everyday Health Team up to Provide Patients with Coronavirus Updates

OurCrowd

Medisafe, a leading digital therapeutics company providing medication management solutions for patients across the healthcare continuum, announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services.

[DarioHealth in Yahoo Finance] DarioHealth Self-test Blood Glucose Meters Can Now Be Utilized Within Hospitals During the COVID-19 Pandemic Per Recently Issued Emergency FDA Guidelines

OurCrowd

Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S.

[DarioHealth in Yahoo Finance] DarioHealth Expands Offering to Include Behavioral Health

OurCrowd

NEW YORK, May 4, 2020 /PRNewswire/ — DarioHealth Corp.

[BrightInsight in Forbes] Four Strategies For Scaling Digital Health Solutions

OurCrowd

Digital health is a new and challenging space for life sciences. The DTx Alliance’s best practices for digital therapeutics advise would-be developers to design products to optimize adoption, engagement and adherence within their target populations.

[Medisafe in Vator News] Today’s entrepreneur: Omri Shor

OurCrowd

Today’s entrepreneur is Omri Shor is co-founder and CEO of Medisafe, a digital therapeutic companion company helping patients manage their treatment journey and medication therapies, which just raised a $30 million round of funding.

[Medisafe in HIT Consultant] Medisafe launches digital document exchange to speed up medication approvals

OurCrowd

. Today, Medisafe, a leading digital therapeutics and patient engagement company launches its new Digital Document Exchange module to streamline the medication approval process.

BrainCheck brings in another $10M to detect, manage cognitive impairment

TechCrunch

As the world’s population ages, more is being learned about brain health as startups leverage technology to find a way to slow down cognitive impairment.

Limbix releases clinical trial data on a self-guided mental health app for teens

TechCrunch

In October, Limbix, a company creating digital therapeutics for adolescents, released data from a trial on its new product: SparkRx. As one review paper in NPJ Digital Medicine notes, the median 15-day retention rate for mental health apps tends to be about 3.9%. .

[DarioHealth in FDA Health News] DARIOHEALTH: Self-test Blood Glucose Meters Can Now Be Utilized Within Hospitals During the COVID-19 Pandemic Per Recently Issued Emergency FDA Guidelines

OurCrowd

Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. DarioHealth Corp.

[DarioHealth in Yahoo Finance] DarioHealth Digital Diabetes Management System is Now Available at Albertsons

OurCrowd

NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of its digital therapeutics solution for managing chronic diseases such as diabetes and hypertension on Albertsons Marketplace. The post [DarioHealth in Yahoo Finance] DarioHealth Digital Diabetes Management System is Now Available at Albertsons appeared first on OurCrowd. DarioHealth Corp.

MedRhythms raises $25M to get patients back in tune after a stroke

TechCrunch

MedRhythms secured $25 million in Series B funding to advance its digital therapy platform aimed at measuring and improving someone’s ability to walk after they have experienced a neurologic injury or disease.

Atommerce wants to scale its mental health platform with $16.7M funding

TechCrunch

With the recent funding, Atommerce plans to enhance artificial intelligence and machine learning technology for its platform and invest in digital therapeutics specialized in mental illness.

[DarioHealth in PR Newswire] DarioHealth Presents Three New Studies Demonstrating Improved Health in Users with Multiple Conditions at the American Diabetes Association’s 82nd Scientific Sessions

OurCrowd

Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today three new research studies presented at the American Diabetes Association’s (“ADA”) 82 nd Scientific Sessions being held June 3 rd to 7 th , 2022 in New Orleans, Louisiana.

Vira Health gets $12M to dial up personalized menopause support

TechCrunch

startup that offers personalized digital therapeutics for women going through menopause, has closed a second round of funding — taking $12 million from lead investor Octopus Ventures, along with participation from U.S.-based Vira Health , a U.K.

[Medisafe in McNight’s] Medisafe Maestro aims to bring precision to medication adherence

OurCrowd

Digital therapeutics companion platform Medisafe has deployed its new Maestro platform, which aims to orchestrate medication adherence journeys with precision and speed and create personalized patient support resources.